Legend Biotech Director Proposes $259K Share Sale

Fidelity Brokerage Services LLC is listed as the broker for the proposed ADS sale.

Rhea-AI Filing Summary

Legend Biotech Corp (LEGN) director Corazon (Corsee) D. Sanders reported a proposed sale of 13,685 American Depositary Shares, with an aggregate market value of $258,914.97 and an approximate sale date of September 29, 2026. Fidelity Brokerage Services LLC is listed as the broker, and the sale schedule attributes the shares to restricted-stock vesting.

Key Figures

American Depositary Shares proposed for sale: 13,685 American Depositary Shares Aggregate market value: $258,914.97 American Depositary Shares outstanding: 369,886,369 American Depositary Shares

3 metrics

American Depositary Shares proposed for sale 13,685 American Depositary Shares Proposed sale by Corazon (Corsee) D. Sanders

Aggregate market value $258,914.97 Proposed sale

American Depositary Shares outstanding 369,886,369 American Depositary Shares Outstanding count reported in the securities information

Key Terms

American Depositary Shares, Restricted Stock Vesting, Rule 144, attorney-in-fact

4 terms

American Depositary Shares technical

"American Depositary Shares"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

Restricted Stock Vesting financial

"Restricted Stock Vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

attorney-in-fact technical

"as attorney-in-fact for Corazon D. Sanders"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LEGN American Depositary Shares does Corazon Sanders propose to sell?

Legend Biotech director Corazon (Corsee) D. Sanders reported a proposed sale of 13,685 American Depositary Shares with an aggregate market value of $258,914.97. The approximate sale date is September 29, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/29/2026 - 02:32 PM Accepted by SEC EDGAR 09/29/2026 - 02:31 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001796536
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Legend Biotech Corp
SEC File Number	001-39307
Address of Issuer	2101 COTTONTAIL LANE SOMERSET NEW JERSEY 08873
Phone	732-850-5598
Name of Person for Whose Account the Securities are To Be Sold	Sanders Corazon (Corsee) D.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
American Depositary Shares	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	13685	258914.97	369886369	09/29/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
American Depositary Shares	06/20/2021	Restricted Stock Vesting	Issuer			2899	06/20/2021	Compensation
American Depositary Shares	09/20/2021	Restricted Stock Vesting	Issuer			724	09/20/2021	Compensation
American Depositary Shares	12/20/2021	Restricted Stock Vesting	Issuer			725	12/20/2021	Compensation
American Depositary Shares	03/20/2022	Restricted Stock Vesting	Issuer			724	03/20/2022	Compensation
American Depositary Shares	06/20/2022	Restricted Stock Vesting	Issuer			2353	06/20/2022	Compensation
American Depositary Shares	09/20/2022	Restricted Stock Vesting	Issuer			1131	09/20/2022	Compensation
American Depositary Shares	12/20/2022	Restricted Stock Vesting	Issuer			1132	12/20/2022	Compensation
American Depositary Shares	03/20/2023	Restricted Stock Vesting	Issuer			1131	03/20/2023	Compensation
American Depositary Shares	06/20/2023	Restricted Stock Vesting	Issuer			1133	06/20/2023	Compensation
American Depositary Shares	09/20/2023	Restricted Stock Vesting	Issuer			407	09/20/2023	Compensation
American Depositary Shares	12/20/2023	Restricted Stock Vesting	Issuer			258	12/20/2023	Compensation
American Depositary Shares	09/20/2026	Restricted Stock Vesting	Issuer			1068	09/20/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/29/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Corazon D. Sanders
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)